Home
Publishers
Categories
Trending
Inbox

Create Account
Sign in

- Nederlands
- Deutsch

Experimental antiviral for COVI D-19 effective in hamster study

Click here to subscribe to Niaid.nih.gov

Loading...

3 years ago

Html
Text

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

Experimental antiviral for COVID-19 effective in hamster study 04/16/2021 10:00 AM EDT
MK-4482 shows potential to prevent and treat SARS-CoV-2 infection.

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

Share on

Loading...

Other newsletters from Niaid.nih.gov

Come back to HealthCare.gov to review your options Niaid.nih.gov
Yesterday at 15:22
Noteworthy: National Institute on Alcohol Abu se and Alcoholism Publishes New Strategic Plan Niaid.nih.gov
Yesterday at 14:48
Salivary Enzyme Behind Our Carb Craving s May Have Unexpectedly Ancient History Niaid.nih.gov
Yesterday at 14:05

More newsletters from Niaid.nih.gov

Loading...

Related newsletters

© 2024

Information
Terms and Conditions
Privacy

Home
Publishers
Categories
Trending
Inbox

Create Account
Sign in

© 2024

Information
Terms and Conditions
Privacy

- Nederlands
- Deutsch